5 results about "Cuscuta" patented technology

The invention discloses algicidal bacteria TH41 and application thereof in inhibiting cyanobacterial bloom, and belongs to the technical field of biology. The algicidal bacterium TH41 is identified as bacillus pumilus TH41 and is preserved in the Guangdong Microbial Culture Collection Center, and the preservation number of the algicidal bacterium TH41 is GDMCC No: 66948. The invention also provides an algicidal bacterial agent containing the algicidal bacteria TH41. The invention further provides application of the algicidal bacterium TH41 or the algicidal fungicide in inhibiting cyanobacterial bloom. The algicidal bacterium TH41 has a degradation effect on harmful blue-green algae, has an efficient blue-green algae inhibition effect, has biological safety on daphnia magna and zebra fish in an algae killing concentration range, is suitable for preventing and treating various blue-green algae such as microcystis aeruginosa, cuscuta larakii, pichia mold and anabaena pseudosciaena, and has a wide application prospect.

The invention relates to the technical field of traditional Chinese medicine, and discloses a plant combined extracting solution for treating protrusion and bulging of intervertebral disc and a preparation method thereof, the plant combined extracting solution comprises plant extract powder and medicinal liquor, and the plant combined extracting solution, tincture and paste disclosed by the invention. The medicine comprises radix trichosanthis, cortex phellodendri, rheum officinale, turmeric, radix angelicae, purple officinal magnolia bark, Guangdong pericarpium citri reticulatae, liquorice, rhizoma atractylodis, erycibe obtusifolia benth, cinnamon, angelica sinensis, radix scrophulariae, radix paeoniae rubra, radix rehmanniae, semen momordicae, sophora japonica twig, willow branch, frankincense, myrrh, ephedra, notopterygium root, ligusticum wallichii, rhizoma cyperi, elecampane, fructus aurantii, rhizoma atractylodis macrocephalae, semen cuscutae, fennel, semen armeniacae amarae, rhizoma alismatis, fructus gleditsiae, moutan bark, fructus psoraleae, rhizoma polygonati and Chinese yam. 36 plants are compounded, a liquor agent, a tincture, a fluid extract agent and an extract agent can be obtained by adopting an extraction method, and a certain agent extracted from the plants is directly externally applied to a part during treatment, so that a brand-new effective external application treatment scheme for treating the protrusion and bulge of the intervertebral disc and complications of the protrusion and bulge of the intervertebral disc is provided.

This invention discloses a TaqMan real-time fluorescent PCR detection primer and probe set, kit, and detection method for Cuscuta pentaphyllum. The primer and probe set includes: an upstream primer C. pan F, whose nucleotide sequence is shown in SEQ ID NO.1; a downstream primer C. pan R, whose nucleotide sequence is shown in SEQ ID NO.2; and a TaqMan probe C. pan P, whose nucleotide sequence is shown in SEQ ID NO.3. The primers and probe target specific fragments of the rbcL gene sequence of Cuscuta pentaphyllum, achieving specific recognition of Cuscuta pentaphyllum through sequence complementarity matching. This avoids false positive results caused by cross-reactions with closely related species and host plants at the molecular targeting level, effectively solving the problem of difficulty in distinguishing closely related species in traditional morphological identification. Compared with traditional morphological identification and conventional PCR, this invention also features high detection efficiency, short processing time, simple operation, and wide applicability. It is suitable for precise identification in professional laboratories and can also meet the practical applications in grassroots quarantine and field monitoring scenarios.

The invention relates to a pimpinella thellungiana compound preparation and a preparation method thereof, and belongs to the technical field of osteoporosis, and the pimpinella thellungiana compound preparation is prepared from the following raw materials in parts by weight: 6-10 parts of pimpinella thellungiana, 8-12 parts of semen cuscutae, 5-8 parts of a solid effect adjuvant, 8-12 parts of radix astragali, 6-8 parts of an immune adjuvant and 2-4 parts of a suspension agent. Wherein the solid effect auxiliary agent is prepared from the following raw materials in parts by weight: 3 to 7 parts of fructus rosae laevigatae, 3 to 7 parts of semen astragali complanati, 1 to 3 parts of cortex cinnamomi, 6 to 9 parts of fructus corni and 3 to 6 parts of herba ecliptae; wherein the immune adjuvant is prepared from the following raw materials in parts by weight: 4 to 7 parts of radix ophiopogonis and 2 to 4 parts of fructus schizandrae. According to the traditional Chinese medicine composition, a solid-effect auxiliary agent prepared from fructus rosae laevigatae, flatstem milkvetch seeds, cinnamon, dogwood and eclipta in a proper proportion is matched with semen cuscutae to achieve the effect of regulating sex hormone, and an immune auxiliary agent prepared from radix ophiopogonis and schisandra chinensis in a proper proportion is matched with astragalus membranaceus to achieve the effect of improving immunity; therefore, the semen cuscutae, the solid-effect adjuvant, the astragalus membranaceus and the immune adjuvant are matched with pimpinella thellungiana for use, so that the osteoporosis treatment capability is improved.

The application belongs to the technical field of medicine, and particularly relates to an extraction method and medical use of a Cuscuta plant resin glycoside extract. 1 The H NMR signal is used as a guide to rapidly locate and enrich resin glycoside parts of six Cuscuta plants, and a main resin glycoside component Cus-1 in Cuscuta is obtained by separation. And through the oligoasthenospermia model mouse experiment, it is confirmed that the six resin glycoside parts and Cus-1 all have good oligoasthenospermia treatment activity, and can be used as active ingredients for preparing medicines for preventing or treating oligoasthenospermia, and have wide application.